TW197420B - - Google Patents

Info

Publication number
TW197420B
TW197420B TW081100069A TW81100069A TW197420B TW 197420 B TW197420 B TW 197420B TW 081100069 A TW081100069 A TW 081100069A TW 81100069 A TW81100069 A TW 81100069A TW 197420 B TW197420 B TW 197420B
Authority
TW
Taiwan
Prior art keywords
denotes
formula
image
group
groups
Prior art date
Application number
TW081100069A
Other languages
English (en)
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Application granted granted Critical
Publication of TW197420B publication Critical patent/TW197420B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW081100069A 1991-01-09 1992-01-07 TW197420B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100201A FR2671349B1 (fr) 1991-01-09 1991-01-09 Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.

Publications (1)

Publication Number Publication Date
TW197420B true TW197420B (zh) 1993-01-01

Family

ID=9408550

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081100069A TW197420B (zh) 1991-01-09 1992-01-07

Country Status (14)

Country Link
US (1) US5250543A (zh)
EP (1) EP0494816B1 (zh)
JP (1) JPH07113016B2 (zh)
KR (1) KR100225002B1 (zh)
AT (1) ATE182330T1 (zh)
AU (1) AU648134B2 (zh)
DE (1) DE69229607T2 (zh)
DK (1) DK0494816T3 (zh)
ES (1) ES2136614T3 (zh)
FR (1) FR2671349B1 (zh)
GR (1) GR3031173T3 (zh)
HU (1) HUT61009A (zh)
TW (1) TW197420B (zh)
UA (1) UA27719C2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342195A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Dihydropyridine mit heterocyclisch substituierten Estern
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
FR2758558B1 (fr) * 1997-01-21 1999-04-16 Lafon Labor Nouveaux derives de la 1,4-dihydropyridine et leur utilisation en therapeutique
FR2781225B1 (fr) * 1998-07-17 2000-10-06 Lafon Labor 1,4-dihydropyridines a groupe carbonyl pyridine
FR2781226B1 (fr) * 1998-07-17 2000-10-13 Lafon Labor 1,4-dihydropyridines a groupe carbonyl benzodioxo
FR2781224B1 (fr) * 1998-07-17 2000-10-13 Lafon Labor 1,4-dihydropyridines a groupe sulfonamide
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
CN101643469B (zh) * 2008-12-27 2012-11-21 武汉百科药物开发有限公司 一种盐酸巴尼地平的合成工艺
CN109111431A (zh) * 2018-11-01 2019-01-01 山东仲鹊医药技术有限公司 一种盐酸巴尼地平化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3382204D1 (de) * 1982-10-15 1991-04-18 Kyowa Hakko Kogyo Kk 1,4-dihydropyridin-derivate.
DE3303066A1 (de) * 1983-01-29 1984-12-06 Cassella Ag, 6000 Frankfurt Substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4808603A (en) * 1985-08-14 1989-02-28 Ciba-Geigy Corporation 3,5-diacyl-2,6-dialkyl-4-aryl-1,4-dihydropyridines, their use, and pharmaceutical compositions thereof
US4772596A (en) * 1986-10-09 1988-09-20 Sankyo Company Limited Dihydropyridine derivatives, their preparation and their use
JP2664941B2 (ja) * 1988-07-29 1997-10-22 三共株式会社 １，４―ジヒドロピリジン化合物

Also Published As

Publication number Publication date
HUT61009A (en) 1992-11-30
ES2136614T3 (es) 1999-12-01
DK0494816T3 (da) 2000-01-31
UA27719C2 (uk) 2000-10-16
GR3031173T3 (en) 1999-12-31
KR920014780A (ko) 1992-08-25
ATE182330T1 (de) 1999-08-15
JPH07113016B2 (ja) 1995-12-06
AU648134B2 (en) 1994-04-14
EP0494816B1 (fr) 1999-07-21
FR2671349B1 (fr) 1993-04-23
DE69229607T2 (de) 2000-03-09
JPH05148231A (ja) 1993-06-15
DE69229607D1 (de) 1999-08-26
KR100225002B1 (ko) 1999-10-15
US5250543A (en) 1993-10-05
HU9200069D0 (en) 1992-03-30
AU1006992A (en) 1992-07-16
EP0494816A1 (fr) 1992-07-15
FR2671349A1 (fr) 1992-07-10

Similar Documents

Publication Publication Date Title
MY131501A (en) Process for the prepration of clavulanic acid
TW197420B (zh)
DE69429708D1 (de) Galanthamin Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
MY123083A (en) Acyclic nucleoside derivatives
RU98113525A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования тромботического расстройства, для увеличения активации протеина с
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ZA856403B (en) Tricyclic oxindole antiinflammatory agents
TW343975B (en) New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents
TW334425B (en) Annelated dihydropyridines for preparing pharmaceutical preparations
NO910137D0 (no) Hemihydrat.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
TW333528B (en) Adhesion receptor antagonists
ATE194350T1 (de) Antiallergisch triazolo (pyrrolo, thieno oder furano) azepinderivate
GB8709547D0 (en) Organic compounds
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
GR3019362T3 (en) Tetrahydronaphtalene derivatives, their preparation and their application in therapy